21
Participants
Start Date
December 7, 2004
Primary Completion Date
June 26, 2008
Study Completion Date
April 27, 2010
Tenofovir
300 mg once daily
Abacavir
600 mg once daily
USC, Los Angeles
Harbor-UCLA Medical Center, Torrance
University of California San Diego, San Diego
UCI, Irvine
Santa Clara Valley Medical Center, San Jose
Collaborators (1)
Universitywide AIDS Research Program
OTHER
GlaxoSmithKline
INDUSTRY
University of California, Irvine
OTHER
University of California, Los Angeles
OTHER
University of Southern California
OTHER
Santa Clara Valley Medical Center
OTHER
University of California, San Diego
OTHER